Sphera Funds Management
Latest statistics and disclosures from Sphera Funds Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MLYS, TEVA, TSEM, XBI, NVMI, and represent 23.00% of Sphera Funds Management's stock portfolio.
- Added to shares of these 10 stocks: MLYS (+$24M), XBI (+$17M), CYTK (+$14M), AZN (+$12M), BBIO (+$10M), CLBT (+$8.7M), PANW (+$8.5M), ORA (+$7.6M), XENE (+$7.4M), AMZN (+$6.7M).
- Started 20 new stock positions in ORGO, PANW, AZN, CTMX, ORA, ZBIO, XENE, UPB, Generate Biomedicines Ord, OVID. IRON, AMZN, AAOI, FHTX, CLBT, Satellos Bioscience, CRIS, BHVN, OLMA, RLAY.
- Reduced shares in these 10 stocks: AstraZeneca (-$12M), PRAX (-$12M), SEDG (-$7.3M), ANNX (-$6.6M), ORIC (-$5.9M), NICE (-$5.5M), Astria Therapeutics, DYN, TNGX, AMD.
- Sold out of its positions in AMD, ANNX, Applied Therapeutics, AstraZeneca, Astria Therapeutics, AVGO, DAWN, TRDA, CATX, JANX. JSPR, MREO, NRIX, OKUR, PEPG, PRAX, TARA, TSHA, TNYA, VRNS, VTYX, ESLT, PHVS.
- Sphera Funds Management was a net buyer of stock by $68M.
- Sphera Funds Management has $630M in assets under management (AUM), dropping by 21.73%.
- Central Index Key (CIK): 0001496201
Tip: Access up to 7 years of quarterly data
Positions held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 95 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Mineralys Therapeutics (MLYS) | 5.8 | $36M | +198% | 1.3M | 27.09 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 5.4 | $34M | 1.1M | 30.12 |
|
|
| Tower Semiconductor Shs New (TSEM) | 4.1 | $26M | +18% | 146k | 175.48 |
|
| Spdr Series Trust State Street Spd Put Option (XBI) | 4.1 | $26M | +185% | 200k | 127.73 |
|
| NOVA MEASURING Instruments L (NVMI) | 3.7 | $23M | +11% | 53k | 434.28 |
|
| Cytokinetics Com New (CYTK) | 3.1 | $20M | +226% | 299k | 65.91 |
|
| Bridgebio Pharma (BBIO) | 2.9 | $18M | +127% | 245k | 74.26 |
|
| Biogen Idec (BIIB) | 2.7 | $17M | -2% | 93k | 183.33 |
|
| Ultragenyx Pharmaceutical (RARE) | 2.7 | $17M | +24% | 809k | 20.95 |
|
| Syndax Pharmaceuticals (SNDX) | 2.7 | $17M | -4% | 725k | 23.36 |
|
| Cogent Biosciences (COGT) | 2.5 | $16M | +9% | 416k | 38.49 |
|
| Sanofi Sa Sponsored Adr (SNY) | 2.1 | $13M | +12% | 270k | 48.18 |
|
| Astrazeneca Ord (AZN) | 2.0 | $12M | NEW | 63k | 197.22 |
|
| Amicus Therapeutics (FOLD) | 1.4 | $8.7M | -8% | 603k | 14.46 |
|
| Cellebrite Di Ordinary Shares (CLBT) | 1.4 | $8.7M | NEW | 632k | 13.78 |
|
| Apellis Pharmaceuticals (APLS) | 1.4 | $8.6M | -14% | 215k | 40.23 |
|
| Palo Alto Networks (PANW) | 1.3 | $8.5M | NEW | 53k | 160.32 |
|
| Eli Lilly & Co. (LLY) | 1.3 | $8.3M | 9.0k | 919.77 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 1.3 | $8.2M | +3% | 867k | 9.52 |
|
| Camtek Ord (CAMT) | 1.3 | $8.0M | +34% | 53k | 151.61 |
|
| BioMarin Pharmaceutical (BMRN) | 1.3 | $7.9M | -4% | 140k | 56.49 |
|
| Celldex Therapeutics Com New (CLDX) | 1.2 | $7.7M | 244k | 31.72 |
|
|
| Ormat Technologies (ORA) | 1.2 | $7.6M | NEW | 68k | 111.92 |
|
| Xenon Pharmaceuticals (XENE) | 1.2 | $7.4M | NEW | 127k | 58.15 |
|
| Soleno Therapeutics (SLNO) | 1.1 | $7.2M | +58% | 216k | 33.48 |
|
| Tango Therapeutics (TNGX) | 1.1 | $7.2M | -36% | 344k | 20.92 |
|
| Johnson & Johnson (JNJ) | 1.1 | $7.0M | -19% | 29k | 244.44 |
|
| Solaredge Technologies Note 2.250% 7/0 | 1.1 | $6.9M | 4.0M | 1.73 |
|
|
| Immatics SHS (IMTX) | 1.1 | $6.8M | -19% | 696k | 9.84 |
|
| Trevi Therapeutics (TRVI) | 1.1 | $6.8M | -4% | 574k | 11.93 |
|
| Oric Pharmaceuticals (ORIC) | 1.1 | $6.8M | -46% | 538k | 12.67 |
|
| Maze Therapeatics (MAZE) | 1.1 | $6.8M | +216% | 227k | 29.85 |
|
| GSK Sponsored Adr (GSK) | 1.1 | $6.7M | 122k | 55.19 |
|
|
| Amazon (AMZN) | 1.1 | $6.7M | NEW | 32k | 208.27 |
|
| Abbvie (ABBV) | 1.0 | $6.6M | +19% | 30k | 217.49 |
|
| Applied Optoelectronics (AAOI) | 1.0 | $6.2M | NEW | 73k | 84.59 |
|
| Enliven Therapeutics (ELVN) | 1.0 | $6.0M | -32% | 153k | 39.20 |
|
| Merck & Co (MRK) | 0.9 | $5.8M | 49k | 120.29 |
|
|
| Vor Biopharma Com New (VOR) | 0.9 | $5.7M | -21% | 322k | 17.84 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.9 | $5.7M | +20% | 256k | 22.26 |
|
| Novartis Sponsored Adr (NVS) | 0.9 | $5.7M | 37k | 152.75 |
|
|
| Eledon Pharmaceuticals (ELDN) | 0.9 | $5.5M | -16% | 1.8M | 3.08 |
|
| 4068594 Enphase Energy (ENPH) | 0.9 | $5.4M | -23% | 142k | 37.81 |
|
| Revolution Medicines (RVMD) | 0.9 | $5.4M | +4% | 55k | 97.25 |
|
| Pfizer (PFE) | 0.8 | $5.2M | +116% | 186k | 28.08 |
|
| Biohaven (BHVN) | 0.8 | $5.0M | NEW | 594k | 8.46 |
|
| Forte Biosciences Com New (FBRX) | 0.8 | $4.8M | 185k | 25.90 |
|
|
| Cybin Com New (HELP) | 0.8 | $4.7M | +19% | 987k | 4.80 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.8 | $4.7M | +173% | 9.0k | 523.47 |
|
| Scholar Rock Hldg Corp (SRRK) | 0.7 | $4.6M | -40% | 94k | 49.16 |
|
| Novo-nordisk A S Adr (NVO) | 0.7 | $4.4M | +4% | 121k | 36.75 |
|
| Mediwound Shs New (MDWD) | 0.7 | $4.4M | +18% | 273k | 16.11 |
|
| Kodiak Sciences (KOD) | 0.7 | $4.4M | -34% | 115k | 38.12 |
|
| Zenas Biopharma (ZBIO) | 0.7 | $4.2M | NEW | 214k | 19.55 |
|
| Promis Neurosciences Com Shs (PMN) | 0.7 | $4.1M | +2657% | 326k | 12.70 |
|
| Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT) | 0.6 | $4.1M | 47k | 86.69 |
|
|
| Relay Therapeutics (RLAY) | 0.6 | $4.1M | NEW | 408k | 9.95 |
|
| Savara (SVRA) | 0.6 | $4.0M | -37% | 739k | 5.46 |
|
| Wave Life Sciences SHS (WVE) | 0.6 | $4.0M | +34% | 548k | 7.25 |
|
| Corvus Pharmaceuticals (CRVS) | 0.6 | $3.6M | -39% | 248k | 14.63 |
|
| Ovid Therapeutics (OVID) | 0.6 | $3.6M | NEW | 1.6M | 2.22 |
|
| Disc Medicine (IRON) | 0.5 | $3.4M | NEW | 54k | 63.94 |
|
| Upstream Bio (UPB) | 0.5 | $3.2M | NEW | 358k | 9.00 |
|
| Alpha Cognition Com New (ACOG) | 0.5 | $3.1M | 568k | 5.49 |
|
|
| Palisade Bio (PALI) | 0.5 | $3.0M | +841% | 1.7M | 1.75 |
|
| Dyne Therapeutics (DYN) | 0.5 | $2.9M | -59% | 161k | 18.13 |
|
| Eliem Therapeutics (CLYM) | 0.5 | $2.9M | -55% | 419k | 6.85 |
|
| Zim Integrated Shipping Serv SHS (ZIM) | 0.4 | $2.8M | -22% | 106k | 26.35 |
|
| Satellos Bioscience | 0.4 | $2.8M | NEW | 489k | 5.63 |
|
| Solaredge Technologies (SEDG) | 0.4 | $2.7M | -73% | 53k | 51.05 |
|
| Amgen (AMGN) | 0.4 | $2.6M | 7.5k | 351.85 |
|
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $2.4M | +23% | 51k | 48.20 |
|
| Kura Oncology (KURA) | 0.4 | $2.4M | 296k | 8.13 |
|
|
| Generate Biomedicines Com Shs | 0.4 | $2.3M | NEW | 185k | 12.50 |
|
| Ishares Bitcoin Trust Etf Shs Ben Int (IBIT) | 0.4 | $2.3M | +97% | 60k | 38.42 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.4 | $2.3M | 174k | 13.06 |
|
|
| Tenax Therapeutics Com New (TENX) | 0.3 | $2.2M | -28% | 136k | 15.99 |
|
| Prelude Therapeutics (PRLD) | 0.3 | $1.9M | +354% | 558k | 3.42 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.3 | $1.8M | -27% | 8.0k | 228.73 |
|
| Verastem Com New (VSTM) | 0.3 | $1.8M | 344k | 5.30 |
|
|
| Voyager Therapeutics (VYGR) | 0.3 | $1.8M | +38% | 470k | 3.86 |
|
| Shattuck Labs (STTK) | 0.3 | $1.8M | +43% | 281k | 6.43 |
|
| Evommune Com Shs (EVMN) | 0.3 | $1.8M | -52% | 78k | 22.99 |
|
| Bioage Labs (BIOA) | 0.2 | $1.5M | -64% | 87k | 17.49 |
|
| Olema Pharmaceuticals Call Option (OLMA) | 0.2 | $1.5M | NEW | 100k | 14.91 |
|
| Organogenesis Hldgs (ORGO) | 0.2 | $1.3M | NEW | 550k | 2.37 |
|
| Curis (CRIS) | 0.2 | $1.1M | NEW | 2.0M | 0.55 |
|
| Bristol Myers Squibb (BMY) | 0.2 | $1.1M | 18k | 60.65 |
|
|
| Cytomx Therapeutics (CTMX) | 0.2 | $1.0M | NEW | 220k | 4.70 |
|
| Nice Sponsored Adr (NICE) | 0.1 | $619k | -89% | 5.6k | 110.26 |
|
| Werewolf Therapeutics (HOWL) | 0.1 | $522k | 627k | 0.83 |
|
|
| Skye Bioscience Com New (SKYE) | 0.1 | $417k | +41% | 679k | 0.61 |
|
| Precision Biosciences Com New (DTIL) | 0.0 | $220k | -89% | 40k | 5.50 |
|
| Aprea Therapeutics Com New (APRE) | 0.0 | $206k | 270k | 0.76 |
|
|
| Foghorn Therapeutics (FHTX) | 0.0 | $58k | NEW | 12k | 4.78 |
|
Past Filings by Sphera Funds Management
SEC 13F filings are viewable for Sphera Funds Management going back to 2013
- Sphera Funds Management 2026 Q1 filed May 15, 2026
- Sphera Funds Management 2025 Q4 filed Feb. 17, 2026
- Sphera Funds Management 2025 Q3 filed Nov. 14, 2025
- Sphera Funds Management 2025 Q2 filed Aug. 14, 2025
- Sphera Funds Management 2025 Q1 filed May 15, 2025
- Sphera Funds Management 2024 Q4 filed Feb. 14, 2025
- Sphera Funds Management 2024 Q3 filed Nov. 14, 2024
- Sphera Funds Management 2024 Q2 filed Aug. 14, 2024
- Sphera Funds Management 2024 Q1 filed May 15, 2024
- Sphera Funds Management 2023 Q4 restated filed Feb. 15, 2024
- Sphera Funds Management 2023 Q4 filed Feb. 14, 2024
- Sphera Funds Management 2023 Q3 filed Nov. 14, 2023
- Sphera Funds Management 2023 Q2 filed Aug. 14, 2023
- Sphera Funds Management 2023 Q1 filed May 15, 2023
- Sphera Funds Management 2022 Q4 filed Feb. 14, 2023
- Sphera Funds Management 2022 Q3 filed Nov. 14, 2022